Načítá se...
In silico comparison of pharmacokinetic properties of three extended half-life factor IX concentrates
PURPOSE: Pharmacokinetic (PK) differences between the extended half-life (EHL) factor IX (FIX) concentrates for hemophilia B exist, which may influence hemostatic efficacy of replacement therapy in patients. Therefore, we aimed to evaluate the PK properties of three EHL-FIX concentrates and compare...
Uloženo v:
| Vydáno v: | Eur J Clin Pharmacol |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer Berlin Heidelberg
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8275546/ https://ncbi.nlm.nih.gov/pubmed/33624121 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00228-021-03111-2 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|